Interferonalpha-2b

修訂後給付規定.原給付規定.8.2.6.1.Interferonalpha-2a（如Roferon-A）及interferonalpha-2b（如IntronA）（92/10/1、109/7/1）;peginterferonalfa-2a（ ...,ThisdrugisapprovedaroundtheworldforthetreatmentofchronichepatitisC,chronichepatitisB,hairycellleukemia,Behçet'sdisease,chronicmyelogenous ...,ChronichepatitisB.TreatmentofadultpatientswithchronichepatitisBassociatedwithevidenceofhepatitisBviralrepl...

參考資訊如下
健保署公告：修訂Interferon alpha-2a （如Roferon

修訂後給付規定. 原給付規定. 8.2.6.1.Interferon alpha-2a （如Roferon-A）及interferon alpha-2b（如Intron A）（92/10/1、109/7/1）; peginterferon alfa-2a（ ...

Interferon alfa

This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, Behçet's disease, chronic myelogenous ...

INTRON A, interferon alfa

Chronic hepatitis B. Treatment of adult patients with chronic hepatitis B associated with evidence of hepatitis B viral replication (presence of DNA of ...

【篤實關懷倫理卓越】光田綜合醫院Kuang Tien General ...

藥理作用 · 1. Pegylated干擾素α-2a的製造方式是將PEG試劑(bis-monomethoxypolyethylene glycol) 和干擾素α-2a (interferon alfa-2a) 結合。 · 適應症 · 治療慢性C型肝炎及 ...

Human Interferon Alpha-2b

由 RA Ningrum 著作 · 2014 · 被引用 144 次 — hIFNα-2b is a protein that has anticancer activity. It has been approved by the FDA as a therapeutic protein that can be used to treat some ...

3440

2023年12月25日 — Interferon alpha 2 regulates MAPK and STAT1 pathways in human hepatoma cells. Degos disease is a distinct vascular injury syndrome whereby a ...

Interferon Alfa-2B Solution

This medication is used to treat various cancers (such as leukemia, melanoma, AIDS-related Kaposi's sarcoma). It is also used to treat virus infections ...

台灣藥物臨床試驗資訊網

對未曾接受干擾素α治療的基因型2/3慢性C型肝炎患者，評估每4週使用一次albinterferon alfa-2b合併雷巴威林之安全性與療效的一項開放性、隨機分配、多中心、活性控制組、 ...

Ropeginterferon alfa-2b

常見副作用包含血小板和白血球數量減少、肌肉關節疼痛、疲憊感、類流感症狀（flu-like symptoms）、血液GGT數值上升等等。其他可能的副作用包含搔癢、上呼吸道感染、 ...